Wound Healing Phases: Hemostasis to Remodeling Explained

The Four Wound Healing Phases in Clinical Practice

Understanding the wound healing phases is foundational to every clinical decision a wound care practitioner makes. Whether you are selecting a dressing, determining debridement frequency, or documenting medical necessity for advanced therapies, the phase of healing dictates the intervention. Wound healing proceeds through four overlapping but distinct phases: hemostasis, inflammation, proliferation, and remodeling. In acute wounds, this process completes within weeks. In chronic wounds, one or more phases stall — and identifying which phase is disrupted is the first step toward getting healing back on track.

This guide walks through each phase, the cellular events that drive it, the clinical signs that mark it, and the factors that derail it.

Phase 1: Hemostasis — The First Minutes

Hemostasis begins within seconds of tissue injury and is the shortest of the wound healing phases. Its purpose is singular: stop the bleeding and establish a provisional matrix that will serve as the scaffold for everything that follows.

Cellular Events and Cascade

When a blood vessel is disrupted, exposed subendothelial collagen triggers platelet adhesion and activation. Platelets aggregate at the injury site and release granule contents — adenosine diphosphate (ADP), thromboxane A2, serotonin, and growth factors including platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta). Simultaneously, the coagulation cascade generates thrombin, which converts fibrinogen to fibrin. The resulting fibrin mesh, interwoven with platelets and trapped red blood cells, forms the hemostatic plug.

This clot does more than stop bleeding. It becomes the provisional extracellular matrix — a temporary scaffold that provides structural support and serves as a reservoir of growth factors and cytokines that will recruit the cells needed for the next phase.

Clinical relevance: Patients on anticoagulants or antiplatelet therapy may have prolonged hemostasis, which can delay clot formation and alter the provisional matrix composition. This does not necessarily prevent wound healing, but it changes bleeding management at the point of care and may affect debridement decisions.

Phase 2: Inflammation — Cleaning and Signaling

The inflammatory phase begins within hours of injury and typically lasts 4 to 6 days in acute wounds. It overlaps with the tail end of hemostasis and serves two critical functions: clearing the wound of bacteria and debris, and releasing the cytokine signals that initiate tissue repair.

The Neutrophil and Macrophage Sequence

Neutrophils are the first immune cells to arrive, migrating to the wound site within hours via chemotaxis. They phagocytose bacteria and cellular debris, release reactive oxygen species (ROS) and proteolytic enzymes, and die — becoming part of the wound exudate. In clean wounds, neutrophil activity peaks within 24 to 48 hours and then declines.

Macrophages arrive next, typically peaking at 48 to 72 hours. Their role is broader and more consequential. Macrophages phagocytose spent neutrophils and remaining debris (efferocytosis), release cytokines and growth factors (PDGF, TGF-beta, vascular endothelial growth factor [VEGF], interleukin-1 [IL-1]), and transition from a pro-inflammatory (M1) to a pro-healing (M2) phenotype. This M1-to-M2 transition is one of the most critical checkpoints in wound healing. When macrophages fail to transition — as occurs in diabetic wounds and other chronic wounds — the wound remains locked in a persistent inflammatory state.

What Disrupts Inflammation

Several factors can prolong or dysregulate the inflammatory phase:

Biofilm sustains a chronic low-grade inflammatory stimulus that prevents macrophage phenotype transition. The wound appears stalled with persistent exudate and friable granulation tissue. See our guide on biofilm management for clinical strategies.
Diabetes impairs neutrophil and macrophage function through hyperglycemia-mediated oxidative stress. Macrophages in diabetic wounds remain in the M1 state longer, producing excess inflammatory cytokines and matrix metalloproteinases (MMPs).
Malnutrition starves the immune response. Protein deficiency directly impairs immune cell production and function. Specific micronutrient deficiencies — zinc, vitamin C, iron — each affect different aspects of the inflammatory response.
Immunosuppressive medications (corticosteroids, chemotherapeutic agents, biologics) blunt the inflammatory response, reducing both the infection-clearing and repair-signaling functions.

Phase 3: Proliferation — Building New Tissue

The proliferative phase typically spans days 4 through 21 in acute wounds, though this timeline is highly variable. This phase involves three concurrent processes: angiogenesis (new blood vessel formation), fibroplasia (connective tissue deposition), and epithelialization (surface coverage).

Granulation Tissue Formation

Fibroblasts migrate into the provisional matrix and begin producing new extracellular matrix components — primarily type III collagen, fibronectin, and hyaluronic acid. This new tissue, rich in new capillaries and fibroblasts, is what clinicians observe as granulation tissue. Healthy granulation tissue is beefy red, moist, and slightly bumpy. Pale, dusky, or friable granulation tissue suggests ischemia, excessive protease activity, or bacterial burden.

Angiogenesis

New capillary formation is driven primarily by VEGF released by macrophages and hypoxic wound edge cells. These new vessels are fragile and essential — they supply the oxygen and nutrients that the metabolically active wound bed requires. Any condition that impairs blood supply (peripheral artery disease, vasoconstriction from smoking, vessel compression from edema) directly limits the proliferative capacity of the wound.

Epithelialization

Keratinocytes at the wound edges and from residual skin appendages (hair follicles, sweat glands) migrate across the granulation tissue surface. They move as a sheet, dissolving attachments at the leading edge and reforming them behind, in a process that requires moisture, viable granulation tissue beneath, and freedom from mechanical disruption. This is why moist wound healing is not a preference — it is a physiological requirement for epithelialization.

What Disrupts Proliferation

Ischemia limits oxygen delivery. Without adequate perfusion, fibroblasts cannot synthesize collagen and angiogenesis stalls.
Excessive moisture (maceration) or inadequate moisture (desiccation) both impair keratinocyte migration.
Protease excess — elevated MMPs in chronic wounds degrade newly deposited extracellular matrix and growth factors faster than they can be produced.
Repeated trauma — including inappropriate dressing changes, pressure, and friction — mechanically disrupts granulation tissue and migrating epithelial cells.

For a comprehensive review of factors that prevent wounds from progressing through the proliferative phase, see why wounds don't heal.

Phase 4: Remodeling — Maturation and Strength

The remodeling phase begins around week 3 and continues for up to two years after wound closure. It is the longest phase and the most frequently overlooked in clinical documentation, though it determines the final quality and durability of the healed tissue.

Collagen Reorganization

During remodeling, type III collagen (deposited during proliferation) is gradually replaced by type I collagen through a continuous process of synthesis and degradation mediated by MMPs and tissue inhibitors of metalloproteinases (TIMPs). The new collagen fibers reorganize along stress lines, and cross-links form between fibers, progressively increasing tensile strength.

The 80% Ceiling

Scar tissue never regains the full strength of uninjured skin. Maximum tensile strength — approximately 80% of original — is typically reached at 12 months. This has direct clinical implications for patients with healed ulcers on weight-bearing surfaces: the tissue remains vulnerable to re-injury, and preventive measures (offloading, protective footwear, skin care) must continue indefinitely.

What Disrupts Remodeling

Excess scarring (hypertrophic scars, keloids) results from an imbalance favoring collagen synthesis over degradation.
Nutritional deficits — particularly vitamin C (required for collagen hydroxylation) and zinc (required for MMP function) — impair the remodeling process.
Mechanical forces — both excessive tension and complete immobilization — affect collagen fiber alignment and scar quality.

Clinical Documentation Across Wound Healing Phases

Accurate documentation of wound phase guides treatment decisions and supports medical necessity. At each visit, the clinician should document:

Observable phase indicators: wound bed tissue type and percentage (necrotic, slough, granulation, epithelial), exudate characteristics, wound edge appearance, and periwound skin condition.
Phase-specific interventions: debridement (inflammation/proliferation transition), dressing selection rationale tied to wound bed status, and advanced therapy justification when standard care has not produced expected phase progression.
Expected vs. actual trajectory: a wound that has not demonstrated >30% area reduction by week 4 is a wound that has stalled. Documenting this trajectory supports referral to advanced therapies and meets LCD requirements for many wound care interventions.

Understanding wound bed preparation through the TIME framework provides a structured approach to addressing phase-specific barriers at each clinical encounter.

Key Takeaways

Wound healing proceeds through four overlapping phases — hemostasis, inflammation, proliferation, and remodeling — each with distinct cellular events and clinical markers.
Chronic wounds most commonly stall at the inflammation-to-proliferation transition, often due to biofilm, diabetes-related macrophage dysfunction, or protease imbalance.
The M1-to-M2 macrophage transition is a critical checkpoint; failure to transition keeps wounds locked in a persistent inflammatory state.
Scar tissue reaches maximum 80% tensile strength at approximately 12 months, making healed ulcers permanently vulnerable to recurrence on weight-bearing surfaces.
Documenting wound phase at each visit directly supports medical necessity, treatment selection, and the >30% four-week trajectory standard required by many LCDs.